Safety of Checkpoint Inhibitors for Cancer Treatment: Strategies for Patient Monitoring and Management of Immune-Mediated Adverse Events

ImmunoTargets and Therapy - New Zealand
doi 10.2147/itt.s141577
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search